A Company Acquires a Patent for a Drug with a Remaining

Multiple Choice

A company acquires a patent for a drug with a remaining legal and useful life of six years on January 1, 2013 for $2,400,000. The company uses straight-line amortization for patents. On January 2, 2015, a new patent is received for a timed-release version of the same drug. The new patent has a legal and useful life of twenty years. The least amount of amortization that could be recorded in 2015 is

A) $400,000.
B) $ 80,000.
C) $109,090.
D) $ 92,000.